These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7581713)

  • 21. Catalytic hydrolysis of VIP in pregnant women with asthma.
    Olopade CO; Yu J; Abubaker J; Mensah E; Paul S
    J Asthma; 2006 Aug; 43(6):429-32. PubMed ID: 16952860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasoactive intestinal peptide: its interactions with calmodulin and catalytic antibodies.
    Paul S; Ebadi M
    Neurochem Int; 1993 Sep; 23(3):197-214. PubMed ID: 8220166
    [No Abstract]   [Full Text] [Related]  

  • 23. A complete substitutional analysis of VIP for better tumor imaging properties.
    Bhargava S; Licha K; Knaute T; Ebert B; Becker A; Grötzinger C; Hessenius C; Wiedenmann B; Schneider-Mergener J; Volkmer-Engert R
    J Mol Recognit; 2002; 15(3):145-53. PubMed ID: 12203840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptidolytic monoclonal antibody elicited by a neuropeptide.
    Paul S; Sun M; Mody R; Tewary HK; Stemmer P; Massey RJ; Gianferrara T; Mehrotra S; Dreyer T; Meldal M
    J Biol Chem; 1992 Jul; 267(19):13142-5. PubMed ID: 1377678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and structural characterization of vasoactive intestinal polypeptide from the trout and bowfin.
    Wang Y; Conlon JM
    Gen Comp Endocrinol; 1995 Apr; 98(1):94-101. PubMed ID: 7781967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular basis and species specificity of high affinity binding of vasoactive intestinal polypeptide by the rat secretin receptor.
    Holtmann MH; Hadac EM; Ulrich CD; Miller LJ
    J Pharmacol Exp Ther; 1996 Nov; 279(2):555-60. PubMed ID: 8930157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening of synthetic peptide libraries with radiolabeled acceptor molecules.
    Kassarjian A; Schellenberger V; Turck CW
    Pept Res; 1993; 6(3):129-33. PubMed ID: 8318743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucose-targeted niosomes deliver vasoactive intestinal peptide (VIP) to the brain.
    Dufes C; Gaillard F; Uchegbu IF; Schätzlein AG; Olivier JC; Muller JM
    Int J Pharm; 2004 Nov; 285(1-2):77-85. PubMed ID: 15488681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasoactive intestinal peptide hydrolysis by antibody light chains.
    Mei S; Mody B; Eklund SH; Paul S
    J Biol Chem; 1991 Aug; 266(24):15571-4. PubMed ID: 1908455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A radiometric assay for Ras-processing peptidase using an enzymatically radiolabeled peptide.
    Georgopapadakou NH; Hall CC; Lambros T; Liu W; Watkins JD
    Anal Biochem; 1994 May; 218(2):273-7. PubMed ID: 8074280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoantibody catalysis: no longer hostage to Occam's razor.
    Paul S
    Ann N Y Acad Sci; 1998 Dec; 865():238-46. PubMed ID: 9928017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the antigen binding site of anti-deoxycholate monoclonal antibody using a novel affinity labeling reagent, acyl adenylate.
    Mano N; Nagaya Y; Saito S; Kobayashi N; Goto J
    Biochemistry; 2004 Feb; 43(7):2041-8. PubMed ID: 14967044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiolabeling of antibodies.
    Eckelman WC; Paik CH; Reba RC
    Cancer Res; 1980 Aug; 40(8 Pt 2):3036-42. PubMed ID: 7397697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular transport mechanisms of radiolabeled amino acids for PET and SPECT.
    Langen KJ; Bröer S
    J Nucl Med; 2004 Sep; 45(9):1435-6. PubMed ID: 15347708
    [No Abstract]   [Full Text] [Related]  

  • 36. Direct evidence for functional coupling of the vasoactive intestinal peptide receptor to Gi3 in native lung membranes.
    Diehl NL; Kermode JC; Shreeve SM
    Mol Pharmacol; 1996 Sep; 50(3):624-30. PubMed ID: 8794903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor.
    Sreedharan SP; Patel DR; Huang JX; Goetzl EJ
    Biochem Biophys Res Commun; 1993 Jun; 193(2):546-53. PubMed ID: 8390245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ac His1 [D-Phe2, K15, R16, L27] VIP (3-7)/GRF (8-27)--a VPAC1 receptor antagonist--is an inverse agonist on two constitutively active truncated VPAC1 receptors.
    Vertongen P; Langlet C; Langer I; Gaspard N; Robberecht P
    Peptides; 2004 Nov; 25(11):1943-9. PubMed ID: 15501526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variants of vasoactive intestinal peptide in mouse mast cells and rat basophilic leukemia cells.
    Wershil BK; Turck CW; Sreedharan SP; Yang J; An S; Galli SJ; Goetzl EJ
    Cell Immunol; 1993 Oct; 151(2):369-78. PubMed ID: 8402943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production and evaluation of VIP antibodies in rabbits.
    Lygren I; Burhol PG; Waldum HL
    Mater Med Pol; 1984; 16(1):26-9. PubMed ID: 6527569
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.